districath® kit of implantable port (titanium-polysulfone) kit of implantable port (titanium)
تراميك للاستيراد -
cosentyx solution for injection
novartis israel ltd - secukinumab - solution for injection - secukinumab 150 mg/ml - secukinumab - - plaque psoriasis: cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. - paediatric plaque psoriasis: cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy. - psoriatic arthritis: cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients when the response to previous disease modifying anti rheumatic drug (dmard) therapy has been inadequate. - axial spondyloarthritis (axspa) : •ankylosing spondylitis (as, radiographic axial spondyloarthritis) cosentyx is indicated for the treatment of active ankylosing spondylitis in adults who have responded inadequately to conventional therapy. •non-radiographic axial spondyloarthritis (nr-axspa) cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) evidence in adults who have responded inadequately to non-steroidal anti-inflammatory drugs (nsaids). - juvenile idiopathic arthritis (jia) •enthesitis-related arthritis (era) cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active enthesitisrelated arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. •juvenile psoriatic arthritis (jpsa) cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.hidradenitis suppurativa (hs)cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic hs therapy
densitin capsule
شركة فارماكير ايجيبت للتوكيلات التجارية بتصريح من أر اكس فيتامينس - انك، أمريكا -
lamictal liquitab 100 mg
مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - lamotrigine 100 mg - 100 mg
lamictal liquitab 25 mg
مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - lamotrigine 25 mg - 25 mg
lamictal liquitab 5 mg
مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - lamotrigine 5 mg - 5 mg
votrex ampoules 75 mg/3ml
شركة أدوية الحكمة - hikma pharmaceuticals - diclofenac sodium 75 mg/3ml - 75 mg/3ml
votrex ampoules 75 mg/3ml
شركة أدوية الحكمة - hikma pharmaceuticals - diclofenac sodium 75 mg/3ml - 75 mg/3ml
votrex ampoules 75 mg/3ml
شركة أدوية الحكمة - hikma pharmaceuticals - diclofenac sodium 75 mg/3ml - 75 mg/3ml
augmentin tab 250 mg, 125 mg
مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - amoxicillin 250 mg, clavulanic acid 125 mg - 250 mg, 125 mg